Patent · US Active

CD47 antibodies and methods of use thereof

US9045541B2 · kind B2 · utility

58Cited by
68References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2013
Grant dateJun 2, 2015
Priority date—
Expiry dateFeb 6, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/21
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates generally to monoclonal antibodies that recognize CD47, more specifically to CD47 antibodies that do not cause a significant level of agglutination of cells, to methods of generating these antibodies, and to methods of using these monoclonal antibodies as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.